TY - JOUR
T1 - A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain
T2 - Modulation of tumor necrosis factor-alpha production by human astrocytic Cells
AU - Wong, Kit Yue
AU - Rajora, Nilum
AU - Boccoli, Giovanni
AU - Catania, Anna
AU - Lipton, James M.
PY - 1997
Y1 - 1997
N2 - The proinflammatory cytokine tumor necrosis factor-α(TNF-α) occurs in CNS tissue in neurological disorders, infection, and injury. Its excessive production is believed to contribute to local pathology, in which case modulation of TNF-αproduction should promote survival of neural tissue. The neuropeptideα-melanocyte stimulating hormone [α-MSH (1-13)] inhibits TNF-αproduction in vivo and in vitro, and in this research we tested the capacity of the peptide, and of an anti-inflammatory COOH-terminal tripeptide fragment of it, to inhibit TNF-αproduction induced by bacterial endotoxin in cells of a human glioma line (A-172, anaplastic astrocytoma cells). Both peptides were effective, although theα-MSH (1–13) sequence was more potent. Preincubation of the cells withα-MSH (1–13) markedly increased its effectiveness. The anticytokine effect ofα-MSH in glioma cells may be mediated by human melanocortin-1 receptors; mRNA for this receptor subtype was isolated from resting A-l 72 cells. These results, combined with prior evidence of effectiveness ofα-MSH molecules in modulating inflammatory processes and of their low toxicity, suggest that the molecules may be useful in the treatment of CNS disorders that have an inflammatory component.
AB - The proinflammatory cytokine tumor necrosis factor-α(TNF-α) occurs in CNS tissue in neurological disorders, infection, and injury. Its excessive production is believed to contribute to local pathology, in which case modulation of TNF-αproduction should promote survival of neural tissue. The neuropeptideα-melanocyte stimulating hormone [α-MSH (1-13)] inhibits TNF-αproduction in vivo and in vitro, and in this research we tested the capacity of the peptide, and of an anti-inflammatory COOH-terminal tripeptide fragment of it, to inhibit TNF-αproduction induced by bacterial endotoxin in cells of a human glioma line (A-172, anaplastic astrocytoma cells). Both peptides were effective, although theα-MSH (1–13) sequence was more potent. Preincubation of the cells withα-MSH (1–13) markedly increased its effectiveness. The anticytokine effect ofα-MSH in glioma cells may be mediated by human melanocortin-1 receptors; mRNA for this receptor subtype was isolated from resting A-l 72 cells. These results, combined with prior evidence of effectiveness ofα-MSH molecules in modulating inflammatory processes and of their low toxicity, suggest that the molecules may be useful in the treatment of CNS disorders that have an inflammatory component.
KW - CNS disorders
KW - Inflammation
KW - Neurological disorders
KW - Tumor necrosis factor-α
KW - α-Melanocyte-stimulating hormone
UR - http://www.scopus.com/inward/record.url?scp=0002858431&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0002858431&partnerID=8YFLogxK
U2 - 10.1159/000097313
DO - 10.1159/000097313
M3 - Article
C2 - 9326743
AN - SCOPUS:0002858431
SN - 1021-7401
VL - 4
SP - 37
EP - 41
JO - NeuroImmunoModulation
JF - NeuroImmunoModulation
IS - 1
ER -